Suppr超能文献

口腔鳞状细胞癌患者治疗结果与生存率的回顾性分析

Retrospective Analysis of Treatment Outcomes and Survival Rates in Oral Squamous Cell Carcinoma Patients.

作者信息

Kukreja Pankaj, Grewal Raman, Tejaswee Annaluru Sri Sasank, Sharma Sanjeev, Maini Anuj Paul, Chandran Thara, Gulia Sunil Kumar

机构信息

Department of Biomedical Dental Sciences, Faculty of Dentistry, Al-Baha University, Al-Aqiq Campus, Kingdom of Saudi Arabia.

Advance Cancer Institute, Bathinda, Punjab, India.

出版信息

J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2440-S2442. doi: 10.4103/jpbs.jpbs_297_24. Epub 2024 Jul 31.

Abstract

BACKGROUND

Because of its high rates of morbidity and death, oral squamous cell carcinoma (OSCC) poses a serious threat to world health. To maximize patient care and direct clinical decision-making, it is important to comprehend treatment results and survival rates.

METHODS

Treatment results and survival rates for OSCC patients treated at a tertiary care facility between 2010 and 2022 were assessed in this retrospective research. Demographic data, tumor features, treatment options, and follow-up results were all included in the data. The relationships between treatment methods and survival rates were evaluated by statistical analysis.

RESULTS

There were 107 OSCC patients in all. Compared to radiation and chemotherapy, surgery had reduced recurrence rates and greater overall survival rates as the most common treatment option. There were notable variations in survival rates across the various treatment regimens ( < 0.05).

CONCLUSION

Surgery is the mainstay. Adjuvant treatments, however, are complementary in the management of illness. The significance of customized treatment strategies based on unique patient attributes and tumor features is highlighted by this study in order to maximize results for patients with OSCC. To confirm these results and investigate cutting-edge treatment approaches, more investigation is necessary.

摘要

背景

口腔鳞状细胞癌(OSCC)因其高发病率和死亡率,对全球健康构成严重威胁。为了最大限度地提高患者护理水平并指导临床决策,了解治疗结果和生存率非常重要。

方法

本回顾性研究评估了2010年至2022年在一家三级医疗机构接受治疗的OSCC患者的治疗结果和生存率。数据包括人口统计学数据、肿瘤特征、治疗选择和随访结果。通过统计分析评估治疗方法与生存率之间的关系。

结果

共有107例OSCC患者。作为最常见的治疗选择,与放疗和化疗相比,手术降低了复发率,提高了总生存率。不同治疗方案的生存率存在显著差异(<0.05)。

结论

手术是主要治疗方法。然而,辅助治疗在疾病管理中具有辅助作用。本研究强调了基于患者独特属性和肿瘤特征制定个性化治疗策略的重要性,以便为OSCC患者实现最佳治疗效果。为了证实这些结果并研究前沿治疗方法,还需要更多的研究。

相似文献

本文引用的文献

1
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.纳武利尤单抗用于复发性头颈部鳞状细胞癌
N Engl J Med. 2016 Nov 10;375(19):1856-1867. doi: 10.1056/NEJMoa1602252. Epub 2016 Oct 8.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验